NCT02419508View on ClinicalTrials.gov

SIMBRINZA® Suspension BID as an Adjunctive to Prostaglandin Analogue (PGA)

PHASE4CompletedINTERVENTIONAL
Enrollment

290

Participants

Timeline

Start Date

August 7, 2015

Primary Completion Date

February 27, 2018

Study Completion Date

February 27, 2018

Conditions
Open-Angle GlaucomaOcular Hypertension
Interventions
DRUG

Brinzolamide 1%/brimonidine 0.2% tartrate ophthalmic suspension

DRUG

Brinz/brim vehicle

Inactive ingredients used as a placebo for masking purposes

DRUG

Prostaglandin analogue

Trial Locations (1)

76134

Contact Alcon Call Center for Trial Locations, Fort Worth

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY